ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025
Head and Neck Tumor Segmentation Using Pre-RT MRI Scans and Cascaded DualUNet.
Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate segmentation of the primary gross tumor volumes and metastatic lymph nodes in head and neck cancer is crucial for radiotherapy but remains challenging due to high interobserver variability, highlighting a need for an effective auto-segmentation tool. Tumor delineation is used throughout radiotherapy for treatment planning, initially for pre-radiotherapy (pre-RT) MRI scans followed-up by mid-radiotherapy (mid-RT) during the treatment. For the pre-RT task, we propose a dual-stage 3D UNet approach using cascaded neural networks for progressive accuracy refinement. The first-stage models produce an initial binary segmentation, which is then refined with an ensemble of second-stage models for a multiclass segmentation. In Head and Neck Tumor Segmentation for MR-Guided Applications (HNTS-MRG) 2024 Task 1, we utilize a dataset consisting of pre-RT and mid-RT T2-weighted MRI scans. The method is trained using 5-fold cross-validation and evaluated as an ensemble of five coarse models and ten refinement models. Our approach (team FinoxyAI) achieves a mean aggregated Dice similarity coefficient of 0.737 on the test set. Moreover, with this metric, our dual-stage approach highlights consistent improvement in segmentation performance across all folds compared to a single-stage segmentation method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.